Skip to content
drillr.ai
Sign up

EDSA

Edesa Biotech, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$4.73
−0.63%
Ask drillr

  • Aug 19, 2026, 20:01 UTC

    Edesa Biotech announced the commencement of an underwritten public offering of its common shares (or pre-funded warrants in lieu thereof) and accompanying common share warrants, with a 30-day option for underwriters to purchase up to 15% additional shares and warrants.

    Source:

  • Aug 13, 2026, 20:15 UTC

    Edesa Biotech reported financial results for the three and nine months ended June 30, 2026.

    Source:

  • Jun 11, 2026, 13:15 UTC

    Edesa Biotech entered into a securities purchase agreement for a $3.5 million private placement of common shares led by its CEO and healthcare-focused investors.

    Source:

  • Jun 5, 2026, 13:20 UTC

    Edesa Biotech reported favorable exploratory data for paridiprubart in patients with acute kidney injury.

    Source: